fluorodeoxyglucose f18 has been researched along with Cardiovascular Tuberculosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baptista, G; Braquet, P; Ilonca, DA; Jeandel, C; Le Moing, V; Roubille, F | 1 |
| Hsich, EM; Oldan, JD; Reynolds, JP; Sperry, BW; Tamarappoo, BK | 1 |
2 other study(ies) available for fluorodeoxyglucose f18 and Cardiovascular Tuberculosis
| Article | Year |
|---|---|
FDG-PET in a myocardial tuberculoma.
Topics: Aged, 80 and over; Antitubercular Agents; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Heart; Humans; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Time Factors; Treatment Outcome; Tuberculoma; Tuberculosis, Cardiovascular | 2015 |
Infectious Myocarditis on FDG-PET Imaging Mimicking Sarcoidosis.
Topics: Diagnosis, Differential; Diagnostic Errors; Fluorodeoxyglucose F18; Humans; Male; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tuberculosis, Cardiovascular; Young Adult | 2015 |